IL6 and neuroblastoma: On the other hand, Penalva-Olcina et al. (2024) also reported an increased IL-6 and TNF-α production after OTA treatment (3.1, 6.25, 12.5 μM), but they observed these alterations in neuroblastoma SH-SY5Y cells, and not in glial model cells.